THE FOUNDATION TO ADVANCE VASCULAR CURES

EIN: 942825216 501(c)(3)

REDWOOD CITY, CA

Total Revenue
$1,853,089
Total Expenses
$1,111,076
Total Assets
$4,309,404
Net Assets
$4,109,366
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1982
Legal Domicile
CA
Principal Officer
ISABEL BJORK
Phone
6503686022
Tax Period
2023-07-01 to 2024-06-30

THE FOUNDATION TO ADVANCE VASCULAR CURES, founded in 1982, is a community nonprofit that reported $1.9M in total revenue in fiscal year 2023. Revenue grew 15% year-over-year, indicating healthy expansion. The organization ran a surplus of $742K, a strong 40% operating margin.

Mission

OUR MISSION: TO ACHIEVE BETTER VASCULAR HEALTH FOR ALL THROUGH A PATIENT-CENTRIC APPROACH TO RESEARCH AND EDUCATION. OUR VISION: A WORLD WHERE EVERYONE EXPERIENCES HEALTHY VASCULAR SYSTEMS - THE ARTERIES AND VEINS THAT SUPPORT THE EFFECTIVE FUNCTIONING OF ALL THE BODY'S ORGANS.

Program Service Accomplishments

Program 1
Expenses: $529,731 Revenue: $276,615

WE SERVE AS A CATALYST FOR INNOVATIVE PROGRAMS THAT SHOW HIGH POTENTIAL TO EFFECT SYSTEMIC CHANGE IN VASCULAR DISEASE. WE DO THIS THROUGH CONVENINGS, SUCH AS THE VASCULAR HEALTH INNOVATION SUMMIT AND...

Read more

WE SERVE AS A CATALYST FOR INNOVATIVE PROGRAMS THAT SHOW HIGH POTENTIAL TO EFFECT SYSTEMIC CHANGE IN VASCULAR DISEASE. WE DO THIS THROUGH CONVENINGS, SUCH AS THE VASCULAR HEALTH INNOVATION SUMMIT AND CLTI/PAD WORKING GROUPS, AND INCUBATION AND RESOURCE SUPPORT FOR EMERGING PROGRAMS, SUCH AS CHAMPIONS (A NATIONAL INTIATIVE THAT SUPPORTS COMMUNITY-BASED SCREENING, AWARENESS RAISING, CAPACITY-BUILDING, AND RESEARCH IN PAD). PROJECT VOICE AND FISCAL SPONSORSHIP OF ALPS ARE EXAMPLES OF PREVIOUS INSTANCES WHERE WE HAVE SERVED IN A CATALYZING CAPACITY.

Program 2
Expenses: $264,145

EDUCATION AND COMMUNITY AWARENESS PROGRAMS RAISE AWARENESS OF THE RISKS, CONSEQUENCES, AND NEW TREATMENTS FOR VASCULAR DISEASE. WE EMPHASIZE EMPOWERMENT AND SHARED DECISION-MAKING BEST PRACTICES...

Read more

EDUCATION AND COMMUNITY AWARENESS PROGRAMS RAISE AWARENESS OF THE RISKS, CONSEQUENCES, AND NEW TREATMENTS FOR VASCULAR DISEASE. WE EMPHASIZE EMPOWERMENT AND SHARED DECISION-MAKING BEST PRACTICES, HELPING TO ENSURE THAT PATIENTS WITH VASCULAR DISEASE AND THEIR FAMILIES ARE EQUIPPED WITH THE KNOWLEDGE TO MAKE INFORMED DECISIONS ABOUT THEIR HEALTH CARE. WE HAVE A SPECIFIC FOCUS ON PREVENTION AND MAKING RESOURCES ACCESSIBLE TO VULNERABLE POPULATIONS AND COMMUNITIES. EVERY YEAR, MORE THAN 200,000 INDIVIDUALS AROUND THE WORLD VISIT OUR WEBSITE TO LEARN ABOUT VASCULAR DISEASE AND CONNECT TO CRITICAL RESOURCES.

Program 3
Expenses: $74,202

THE WYLIE SCHOLAR AWARD AND THE COLLABORATIVE PATIENT-CENTERED RESEARCH AWARD PROVIDE CAREER RESEARCH GRANTS THAT ADVANCE INNOVATION IN VASCULAR RESEARCH. THE WYLIE SCHOLAR AWARD IS GRANTED TO...

Read more

THE WYLIE SCHOLAR AWARD AND THE COLLABORATIVE PATIENT-CENTERED RESEARCH AWARD PROVIDE CAREER RESEARCH GRANTS THAT ADVANCE INNOVATION IN VASCULAR RESEARCH. THE WYLIE SCHOLAR AWARD IS GRANTED TO OUTSTANDING YOUNG VASCULAR SURGEON-SCIENTISTS WHO COMBINE ACTIVE PATIENT CARE WITH ACADEMIC RESEARCH. THE AWARD SUPPORTS CRUCIAL PATIENT-CENTERED RESEARCH THAT ENABLES THEM TO COMPETE FOR FUTURE RESEARCH FUNDING. WYLIE SCHOLARS BECOME NORTH AMERICA'S WORLD-CLASS VASCULAR SURGEON-SCIENTISTS; MANY ARE NOW CHIEFS AT MAJOR ACADEMIC CENTERS, PROMINENT LEADERS IN THE FIELD. SINCE 1996, WE'VE SUPPORTED 25 SURGEON-SCIENTISTS AT 16 INSTITUTIONS AROUND THE COUNTRY WHO ARE TRANSFORMING PATIENT CARE. THE AVERAGE RETURN ON INVESTMENT FOR FOLLOW-ON RESEARCH FUNDING IS 30:1. THE COLLABORATIVE PATIENT CENTERED RESEARCH AWARD PROVIDES SUPPORT FOR PROJECTS THAT OFFER INNOVATIVE APPROACHES WITH DIRECT PATIENT IMPACT AND ARE MULTI-INSTITUTIONAL AND RESPONSIVE TO THE PRIORITIES IDENTIFIED AT OUR ANNUAL VASCULAR HEALTH INNOVATION SUMMIT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,222,426
Program Service Revenue $276,615
Investment Income $353,652
Other Revenue $396
TOTAL REVENUE $1,853,089

Expense Breakdown

Grants Paid $369,218
Salaries & Benefits $507,156
Fundraising Expenses $93,647
Program Expenses $868,078
Other Expenses $234,702
TOTAL EXPENSES $1,111,076

Year-over-Year Comparison

2023 2022 Change
Revenue $1,853,089 $1,610,194 +0.2%
Expenses $1,111,076 $1,826,600 -0.4%
Net Income $742,013 $-216,406 -4.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
12
Employees
9
Volunteers
50

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$230,237
Total Directors
13
$230,237
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ISABEL BJORK SECRETARY, CEO 40.00
Officer Director
$195,000 $35,237 $230,237
EDWARD YU BOARD CHAIR 2.00
Officer Director
$0 $0 $0
DAVID RAE TREASURER 2.00
Officer Director
$0 $0 $0
WENDY HITCHCOCK CO-CHAIR 2.00
Officer Director
$0 $0 $0
MICHAEL CONTE DIRECTOR 2.00
Director
$0 $0 $0
STEVE HAMBURGER DIRECTOR 2.00
Director
$0 $0 $0
MARGARET WONG DIRECTOR 2.00
Director
$0 $0 $0
LILIA COBURN DIRECTOR 2.00
Director
$0 $0 $0
DOUGLAS GREY DIRECTOR 2.00
Director
$0 $0 $0
KEVIN HEATH DIRECTOR 2.00
Director
$0 $0 $0
BOB KAIN DIRECTOR 2.00
Director
$0 $0 $0
MEGAN PATTERSON DIRECTOR 2.00
Director
$0 $0 $0
KATHERINE GALLAGHER DIRECTOR 2.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $1,853,089 $1,111,076 $4,309,404 $742,013
2023 $1,610,194 $1,826,600 $3,574,035 $-216,406
2022 $2,153,452 $2,056,902 $3,787,443 $96,550
2021 $516,547 $806,491 $4,123,824 $-289,944
2020 $1,228,444 $743,410 $3,437,896 $485,034
2019 $1,071,805 $767,918 $2,978,980 $303,887
2018 $497,871 $898,562 $2,764,483 $-400,691
Explore More Nonprofits
Top 100 Nonprofits in California Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare THE FOUNDATION TO ADVANCE VASCULAR CURES with other nonprofits in California and across the country.